The Heart Team referral is the first step towards an optimal treatment decision

It is important that your patients with severe aortic stenosis (sAS) are provided the most appropriate treatment. The 2021 ESC/EACTS VHD guidelines recommend that the Heart Team evaluate treatment options using an individualised approach for every patient. Underpinning this, is the vital collateral information provided by their referring Cardiologist.¹

Putting patients at the centre of the treatment decision

• The 2021 ESC/EACTS VHD guidelines have emphasised the importance to incorporate patients’ values and preferences in the decision between TAVI or SAVR.¹
• A systematic review conducted in 2016 of patient values and preferences on aortic valve replacement therapy² found great variability.²
• The 2021 guidelines have taken the need to tailor care into account by advising that the Heart Team recommendation is discussed with each individual patient to allow them to make a fully informed decision.¹

Our infographic outlines the new referral process and evaluation considerations that could now influence your final treatment decision¹